치주염 겔 시장 분석 및 예측(-2035년) : 유형, 제품 유형, 기술, 구성 요소, 용도, 제형, 최종 사용자, 기능, 솔루션

The global Periodontitis Gels Market is projected to grow from $142.5 million in 2025 to $226.0 million by 2035, at a compound annual growth rate (CAGR) of 4.3%. The Periodontitis Gels Market is characterized by a moderately consolidated structure, with the top three segments comprising antimicrobial gels (40%), anti-inflammatory gels (35%), and regenerative gels (25%). Key applications include dental clinics, hospitals, and home care settings, with dental clinics being the predominant application area. The market volume is primarily measured in units sold, with a significant focus on single-use packaging to ensure hygiene and efficacy.

Based on Type, the Periodontitis Gels Market is divided into Antimicrobial Gels, Anti-inflammatory Gels, Regenerative Gels, and Others. Among these, the Antimicrobial Gels segment accounted for the largest market share in 2025. This dominance is attributed to the increasing prevalence of periodontal infections and the widespread use of antimicrobial formulations to control bacterial growth associated with periodontitis. These gels help reduce pathogenic microorganisms, prevent disease progression, and support conventional periodontal treatments such as scaling and root planing. Growing awareness among dental professionals regarding infection management, rising dental care expenditure, and the availability of advanced antimicrobial formulations with improved retention and targeted action are further contributing to the segments leading position in the market.

Based on Technology, the Periodontitis Gels Market is divided into Controlled Release Technology, Bioadhesive Technology, Nanotechnology, and Others. Among these, the Controlled Release Technology segment is projected to witness the fastest growth during the forecast period. The rapid growth of this segment is driven by the increasing demand for advanced drug delivery systems that provide sustained therapeutic effects within periodontal pockets. Controlled release gels enable prolonged exposure of active ingredients at the treatment site, improving treatment outcomes while reducing the frequency of application. Continuous advancements in dental biomaterials, growing adoption of minimally invasive periodontal therapies, and increasing research activities focused on targeted periodontal drug delivery are expected to accelerate the adoption of controlled release technologies in periodontitis treatment.

Geographical Overview

North America dominated the Periodontitis Gels Market in 2025 due to its advanced dental healthcare infrastructure, high prevalence of periodontal diseases, and strong awareness regarding preventive oral healthcare. The United States and Canada have well-established dental care systems with widespread adoption of advanced localized drug delivery therapies for periodontal treatment. Favorable reimbursement policies, increasing dental insurance coverage, and the presence of leading pharmaceutical and dental product manufacturers further contribute to regional market leadership. Continuous investment in dental research and growing demand for minimally invasive periodontal treatments continue to support sustained market growth.

Asia-Pacific is expected to witness the fastest growth during the forecast period owing to rising awareness of oral hygiene, expanding dental healthcare infrastructure, and increasing prevalence of periodontal diseases. Countries including China, India, Japan, and South Korea are experiencing growing demand for advanced dental treatments driven by improving healthcare access and rising disposable incomes. Government initiatives promoting oral health, increasing numbers of dental clinics, and expanding availability of specialized periodontal therapies are accelerating market growth. Rising healthcare expenditure and growing emphasis on preventive dentistry are expected to create substantial opportunities across the region.

Key Trends and Drivers

Increasing Prevalence of Periodontal Diseases:

The growing incidence of periodontal diseases is a major driver for the Periodontitis Gels Market. Factors such as poor oral hygiene, tobacco consumption, diabetes, aging populations, and unhealthy dietary habits are contributing to a higher prevalence of gingivitis and chronic periodontitis worldwide. Periodontitis gels provide localized drug delivery directly to infected periodontal pockets, improving treatment effectiveness while minimizing systemic side effects. Rising awareness regarding preventive oral healthcare, increasing dental visits, and expanding access to advanced periodontal treatments are further supporting product adoption. Continuous improvements in dental healthcare infrastructure also contribute to the sustained growth of this market.

Development of Bioadhesive and Sustained-Release Gel Formulations:

A significant trend in the Periodontitis Gels Market is the development of bioadhesive and sustained-release formulations that improve localized drug delivery. Manufacturers are introducing advanced gel technologies capable of adhering to periodontal tissues for extended periods, allowing controlled release of antimicrobial and anti-inflammatory agents. These innovations enhance treatment efficacy, reduce the frequency of applications, and improve patient compliance. Ongoing research into biodegradable polymers, nanotechnology-based drug delivery systems, and combination therapies is further expanding product capabilities. These technological advancements are transforming localized periodontal treatment and supporting the development of next-generation therapeutic gels.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Application
• 2.4 Key Market Highlights by End User
• 2.5 Key Market Highlights by Technology
• 2.6 Key Market Highlights by Form
• 2.7 Key Market Highlights by Component
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Antimicrobial Gels
  • 4.1.2 Anti-inflammatory Gels
  • 4.1.3 Regenerative Gels
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Prescription Gels
  • 4.2.2 Over-the-Counter Gels
  • 4.2.3 Herbal Gels
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Application (2020-2035)
  • 4.3.1 Dental Clinics
  • 4.3.2 Hospitals
  • 4.3.3 Home Care
  • 4.3.4 Research Laboratories
  • 4.3.5 Others
• 4.4 Market Size & Forecast by End User (2020-2035)
  • 4.4.1 Dentists
  • 4.4.2 Periodontists
  • 4.4.3 General Practitioners
  • 4.4.4 Patients
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Technology (2020-2035)
  • 4.5.1 Controlled Release Technology
  • 4.5.2 Bioadhesive Technology
  • 4.5.3 Nanotechnology
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Form (2020-2035)
  • 4.6.1 Gel Tubes
  • 4.6.2 Gel Syringes
  • 4.6.3 Gel Packs
  • 4.6.4 Others
• 4.7 Market Size & Forecast by Component (2020-2035)
  • 4.7.1 Active Pharmaceutical Ingredients
  • 4.7.2 Excipients
  • 4.7.3 Others
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Pain Relief
  • 4.8.2 Gum Regeneration
  • 4.8.3 Plaque Reduction
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Treatment Solutions
  • 4.9.2 Preventive Solutions
  • 4.9.3 Maintenance Solutions
  • 4.9.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Application
    • 5.2.1.4 End User
    • 5.2.1.5 Technology
    • 5.2.1.6 Form
    • 5.2.1.7 Component
    • 5.2.1.8 Functionality
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Application
    • 5.2.2.4 End User
    • 5.2.2.5 Technology
    • 5.2.2.6 Form
    • 5.2.2.7 Component
    • 5.2.2.8 Functionality
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Application
    • 5.2.3.4 End User
    • 5.2.3.5 Technology
    • 5.2.3.6 Form
    • 5.2.3.7 Component
    • 5.2.3.8 Functionality
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Application
    • 5.3.1.4 End User
    • 5.3.1.5 Technology
    • 5.3.1.6 Form
    • 5.3.1.7 Component
    • 5.3.1.8 Functionality
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Application
    • 5.3.2.4 End User
    • 5.3.2.5 Technology
    • 5.3.2.6 Form
    • 5.3.2.7 Component
    • 5.3.2.8 Functionality
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Application
    • 5.3.3.4 End User
    • 5.3.3.5 Technology
    • 5.3.3.6 Form
    • 5.3.3.7 Component
    • 5.3.3.8 Functionality
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Application
    • 5.4.1.4 End User
    • 5.4.1.5 Technology
    • 5.4.1.6 Form
    • 5.4.1.7 Component
    • 5.4.1.8 Functionality
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Application
    • 5.4.2.4 End User
    • 5.4.2.5 Technology
    • 5.4.2.6 Form
    • 5.4.2.7 Component
    • 5.4.2.8 Functionality
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Application
    • 5.4.3.4 End User
    • 5.4.3.5 Technology
    • 5.4.3.6 Form
    • 5.4.3.7 Component
    • 5.4.3.8 Functionality
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Application
    • 5.4.4.4 End User
    • 5.4.4.5 Technology
    • 5.4.4.6 Form
    • 5.4.4.7 Component
    • 5.4.4.8 Functionality
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Application
    • 5.4.5.4 End User
    • 5.4.5.5 Technology
    • 5.4.5.6 Form
    • 5.4.5.7 Component
    • 5.4.5.8 Functionality
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Application
    • 5.4.6.4 End User
    • 5.4.6.5 Technology
    • 5.4.6.6 Form
    • 5.4.6.7 Component
    • 5.4.6.8 Functionality
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Application
    • 5.4.7.4 End User
    • 5.4.7.5 Technology
    • 5.4.7.6 Form
    • 5.4.7.7 Component
    • 5.4.7.8 Functionality
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Application
    • 5.5.1.4 End User
    • 5.5.1.5 Technology
    • 5.5.1.6 Form
    • 5.5.1.7 Component
    • 5.5.1.8 Functionality
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Application
    • 5.5.2.4 End User
    • 5.5.2.5 Technology
    • 5.5.2.6 Form
    • 5.5.2.7 Component
    • 5.5.2.8 Functionality
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Application
    • 5.5.3.4 End User
    • 5.5.3.5 Technology
    • 5.5.3.6 Form
    • 5.5.3.7 Component
    • 5.5.3.8 Functionality
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Application
    • 5.5.4.4 End User
    • 5.5.4.5 Technology
    • 5.5.4.6 Form
    • 5.5.4.7 Component
    • 5.5.4.8 Functionality
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Application
    • 5.5.5.4 End User
    • 5.5.5.5 Technology
    • 5.5.5.6 Form
    • 5.5.5.7 Component
    • 5.5.5.8 Functionality
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Application
    • 5.5.6.4 End User
    • 5.5.6.5 Technology
    • 5.5.6.6 Form
    • 5.5.6.7 Component
    • 5.5.6.8 Functionality
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Application
    • 5.6.1.4 End User
    • 5.6.1.5 Technology
    • 5.6.1.6 Form
    • 5.6.1.7 Component
    • 5.6.1.8 Functionality
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Application
    • 5.6.2.4 End User
    • 5.6.2.5 Technology
    • 5.6.2.6 Form
    • 5.6.2.7 Component
    • 5.6.2.8 Functionality
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Application
    • 5.6.3.4 End User
    • 5.6.3.5 Technology
    • 5.6.3.6 Form
    • 5.6.3.7 Component
    • 5.6.3.8 Functionality
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Application
    • 5.6.4.4 End User
    • 5.6.4.5 Technology
    • 5.6.4.6 Form
    • 5.6.4.7 Component
    • 5.6.4.8 Functionality
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Application
    • 5.6.5.4 End User
    • 5.6.5.5 Technology
    • 5.6.5.6 Form
    • 5.6.5.7 Component
    • 5.6.5.8 Functionality
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 3M
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Colgate-Palmolive
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Procter & Gamble
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 GlaxoSmithKline
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Johnson & Johnson
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Sunstar Group
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Dentsply Sirona
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Straumann Group
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Unilever
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Kao Corporation
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 GC Corporation
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Ivoclar Vivadent
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Septodont
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Heraeus Kulzer
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Ultradent Products
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 DenMat Holdings
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Young Innovations
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Mediwin Pharmaceuticals
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Oral-B Laboratories
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Church & Dwight
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us